全文获取类型
收费全文 | 23450篇 |
免费 | 1370篇 |
国内免费 | 795篇 |
专业分类
耳鼻咽喉 | 106篇 |
儿科学 | 274篇 |
妇产科学 | 154篇 |
基础医学 | 2057篇 |
口腔科学 | 76篇 |
临床医学 | 2402篇 |
内科学 | 782篇 |
皮肤病学 | 95篇 |
神经病学 | 2923篇 |
特种医学 | 1634篇 |
外国民族医学 | 3篇 |
外科学 | 8254篇 |
综合类 | 2104篇 |
预防医学 | 354篇 |
眼科学 | 36篇 |
药学 | 927篇 |
5篇 | |
中国医学 | 370篇 |
肿瘤学 | 3059篇 |
出版年
2024年 | 32篇 |
2023年 | 285篇 |
2022年 | 439篇 |
2021年 | 796篇 |
2020年 | 753篇 |
2019年 | 664篇 |
2018年 | 731篇 |
2017年 | 653篇 |
2016年 | 721篇 |
2015年 | 811篇 |
2014年 | 1447篇 |
2013年 | 1818篇 |
2012年 | 1198篇 |
2011年 | 1495篇 |
2010年 | 1184篇 |
2009年 | 1224篇 |
2008年 | 1284篇 |
2007年 | 1176篇 |
2006年 | 1072篇 |
2005年 | 962篇 |
2004年 | 808篇 |
2003年 | 692篇 |
2002年 | 595篇 |
2001年 | 543篇 |
2000年 | 491篇 |
1999年 | 391篇 |
1998年 | 331篇 |
1997年 | 319篇 |
1996年 | 243篇 |
1995年 | 228篇 |
1994年 | 208篇 |
1993年 | 206篇 |
1992年 | 216篇 |
1991年 | 140篇 |
1990年 | 142篇 |
1989年 | 141篇 |
1988年 | 144篇 |
1987年 | 130篇 |
1986年 | 106篇 |
1985年 | 108篇 |
1984年 | 104篇 |
1983年 | 70篇 |
1982年 | 82篇 |
1981年 | 64篇 |
1980年 | 72篇 |
1979年 | 46篇 |
1978年 | 39篇 |
1977年 | 52篇 |
1976年 | 26篇 |
1971年 | 25篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
AimsOligometastatic disease (OMD) represents a spectrum of clinical scenarios and various classification systems have been proposed. Bone-only OMD can occur in patients with advanced prostate cancer and validated decision-making tools are needed to assist patient selection for metastasis-directed therapy. The aim of the present study was to determine the prognostic utility of a classification system for OMD.Materials and methodsA retrospective review was conducted of all patients with bone-only oligometastatic prostate cancer treated with stereotactic body radiotherapy (SBRT) since November 2011. SBRT was delivered using CyberKnife® and gantry-based linear accelerator platforms. All patients were classified into oligometastatic states based on the European Society for Radiotherapy and Oncology/European Organisation for Research and Treatment of Cancer (ESTRO/EORTC) classification system. Kaplan–Meier and Cox regression analyses were carried out to determine the prognostic utility of this classification system.ResultsIn total, 105 patients with 145 osseous metastases were treated over 119 sessions. The median follow-up after SBRT was 23 months (interquartile range 10–39.8). Twelve patients had died after a median time of 31 months. The 3-year metastatic progression-free survival was 23% (95% confidence interval 13–32) and the 3-year overall survival was 88% (95% confidence interval 80–96). Patients in a metachronous oligometastatic state were 4.50 (95% confidence interval 1.19–17.10, P = 0.03) times more likely to experience metastatic progression compared with those with synchronous oligometastases, and 6.69 (95% confidence interval 1.05–42.50, P = 0.04) times more likely to experience any failure. Hazard ratio magnitudes increased for patients in a repeat oligometastatic state. The multivariate model for both metastatic progression-free survival and failure-free survival found prostate-specific antigen doubling time <4 months (P = 0.002; P = 0.05) to independently predict for progression.ConclusionThe ESTRO/EORTC classification of OMD predicts for progression in patients treated with SBRT for bone-only oligometastatic prostate cancer at our institution. Further validation in prospective series over multiple tumour sites is needed. These characterisation factors should be assessed in patients considered for metastasis-directed therapy together with established prognostic features. 相似文献
3.
《European journal of surgical oncology》2022,48(5):1104-1109
BackgroundThis study aimed to describe the treatment of metachronous colorectal cancer metastases in a recent population-based cohort.MethodPatients with stage I-III colorectal cancer (CRC), diagnosed between January 1st and June 30th, 2015 who were surgically treated with curative intent were selected from the Netherlands Cancer Registry. Follow-up was at least 3 years after diagnosis of the primary tumour. Treatment of metachronous metastases was categorized into local treatment, systemic treatment, and best supportive care. Overall survival was estimated using Kaplan-Meier method.ResultsOut of 5412 patients, 782 (14%) developed metachronous metastases, of whom 393 (50%) underwent local treatment (LT) with or without systemic therapy, 30% of patients underwent only systemic therapy (ST) and 19% only best supportive care (BSC). The most common metastatic site was the liver (51%) followed by lungs (33%) and peritoneum (22%). LT rates were 69%, 66%, and 44% for liver-only, lung-only and, peritoneal-only metastases respectively. Patients receiving LT and ST were significantly younger than patients receiving LT alone, while patients receiving BSC were significantly older than the other groups (p < 0.001). Patients with liver-only or lung-only metastases had a 3-year OS of 50.2% (43.3–56.7 95% CI) and 61.5% (50.7–70.6 95% CI) respectively. Patients with peritoneal-only disease had a lower 3-year OS, 18.1% (10.1–28.0 95% CI).ConclusionPatients with metastases confined to the liver and lung have the highest rates of local treatment for metachronous metastatic colorectal cancer. The number of patients who underwent local treatment is higher than reported in previous Dutch and international studies. 相似文献
4.
Cody M. Lebeck Lee MD Ioannis A. Ziogas MD Rajiv Agarwal MD Sophoclis P. Alexopoulos MD Kristen K. Ciombor MD Lea K. Matsuoka MD Daniel B. Brown MD Cathy Eng MD 《Cancer》2022,128(12):2243-2257
The 5-year overall survival rate of a patient with unresectable metastatic colorectal cancer is poor at approximately 14%. Similarly, historical data on liver transplantation (LT) in those with colorectal liver metastases (CRLM) showed poor outcomes, with 5-year survival rates between 12% and 21%. More recently, limited data have shown improved outcomes in select patients with 5-year overall survival rates of approximately 60%. Despite these reported survival improvements, there is no significant improvement in disease-free survival. Given the uncertain benefit with this therapeutic approach and a renewed investigational interest, we aimed to conduct a contemporary systematic review on LT for CRLM. A systematic review of the literature was performed according to the preferred reporting items for systematic reviews and meta-analysis statement. English articles reporting on data regarding LT for CRLM were identified through the MEDLINE (via PubMed), Cochrane Library, and ClinicalTrials.gov databases (last search date: December 16th, 2021) by 2 researchers independently. A total of 58 studies (45 published and 13 ongoing) were included. Although early retrospective studies suggest the possibility that some carefully selected patients may benefit from LT, there is minimal prospective data on the topic and LT remains exploratory in the setting of CRLM. Additionally, several other challenges, such as the limited availability of deceased donor organs and defining appropriate selection criteria, remain when considering the implementation of LT for these patients. Further evidence from ongoing prospective trials is needed to determine if and to what extent there is a role for LT in patients with surgically unresectable CRLM. 相似文献
5.
6.
BackgroundThe epidemiology and clinical characteristics of spinal epidural lipomatosis (SEL) have been well-reported in the literature. However, few studies investigated the concomitant spinal pathologies that were present in patients with SEL. Therefore, we aimed to summarize the clinical and radiological characteristics of patients with SEL diagnosed on spinal imaging.MethodsPatients who were diagnosed with SEL on magnetic resonance imaging from January 2018 to October 2020 at our institution were included in the study. Clinical data was collected using a standardized data collection form. SEL was graded using a modified version of the Borré grading system. Factors associated with moderate or severe SEL were determined using multiple logistic regression.ResultsA total of 90 patients were included in the analysis. The mean (±SD) age was 59.3 (±17.1) years, and 62 patients (68.9%) were male. 61 patients (67.8%) had moderate or severe SEL. Most patients were overweight or obese (57 patients, 63.3%). The most common presenting symptoms was back pain (57 patients, 63.3%). SEL was diagnosed incidentally in 42 patients (46.7%). The lumbar spine was the most common site of SEL (35 patients, 38.9%). The most common concomitant spinal pathologies were disc bulge (83 patients, 92.2%) and flavum hypertrophy (60 patients, 66.7%). Moderate or severe SEL was associated with WHO Obesity Class, back pain or radicular leg pain at first presentation, and SEL that was worst at the lumbar or lumbosacral spinal level.ConclusionsModerate or severe SEL were independently associated with WHO Obesity Class, back pain, radicular leg pain, and SEL that was worst at the lumbar or lumbosacral spinal level. Future studies should prospectively evaluate whether weight loss therapy is warranted in patients with SEL. 相似文献
7.
目的分析长臂单轴椎弓根螺钉经 Wiltse入路在单纯性胸腰椎压缩性骨折中的应用效果及对肌肉损伤的影响。方法选取自 2018年 1月至 2020年 8月周口市中心医院收治的单纯性胸腰椎压缩性骨折病人 87例,根据复位固定术式不同,分为观察组 38例、对照组 49例,其中观察组采取长臂单轴椎弓根螺钉经 Wiltse入路,对照组采取 AF系统经传统后正中入路。记录两组病人围术期指标、手术前后血清肌肉损伤指标[肌酸激酶( CK)、肌红蛋白( Mb)]变化;采用疼痛视觉模拟评分( VAS)评价病人不同时间节点疼痛水平;经胸腰椎正侧位片检查获取伤椎原始高度( H0)、术前及术后 1周伤椎椎体前缘高度( H1H2),计算术前、术后 1周伤椎相对高度( H1/H0、H2/H0)及伤椎复位率,并测量矢状位 Cobb角变化;随访 3个月,采用 Oswestry功能障、碍指数( ODI)评价功能障碍情况,并统计手术相关并发症。结果观察组手术时长、术中失血量、术后引流量及首次下床活动时间均明显短于或低于对照组( P<0.05)。术后 3d,两组血清 CK、Mb水平均较术前升高( P<0.05),且观察组血清 CK、Mb水平 相似文献
8.
BackgroundMachine learning has been applied to improve diagnosis and prognostication of acute traumatic spinal cord injury. We investigate potential for clinical integration of machine learning in this patient population to navigate variability in injury and recovery.Materials and methodsWe performed a systematic review using PRISMA guidelines through PubMed database to identify studies that use machine learning algorithms for clinical application toward improvements in diagnosis, management, and predictive modeling.ResultsOf the 132 records identified, a total of 13 articles met inclusion criteria and were included in final analysis. Of the 13 articles, 5 focused on diagnostic accuracy and 8 were related to prognostication or management of traumatic spinal cord injury. Across studies, 1983 patients with spinal cord injury were evaluated with most classifying as ASIA C or D. Retrospective designs were used in 10 of 13 studies and 3 were prospective. Studies focused on MRI evaluation and segmentation for diagnostic accuracy and prognostication, investigation of mean arterial pressure in acute care and intraoperative settings, prediction of ambulatory and functional ability, chronic complication prevention, and psychological quality of life assessments. Decision tree, random forests (RF), support vector machines (SVM), hierarchical cluster tree analysis (HCTA), artificial neural networks (ANN), convolutional neural networks (CNN) machine learning subtypes were used.ConclusionsMachine learning represents a platform technology with clinical application in traumatic spinal cord injury diagnosis, prognostication, management, rehabilitation, and risk prevention of chronic complications and mental illness. SVM models showed improved accuracy when compared to other ML subtypes surveyed. Inherent variability across patients with SCI offers unique opportunity for ML and personalized medicine to drive desired outcomes and assess risks in this patient population. 相似文献
9.
Andrea Ferrari MD Daniel Orbach MD Michela Casanova MD Max M. van Noesel MD Pablo Berlanga MD Bernadette Brennan MD Nadege Corradini MD Reineke A. Schoot MD Gema L. Ramirez-Villar MD Lisa Lyngsie Hjalgrim MD Rita Alaggio MD Gabriela Guillen Burrieza MD Akmal Safwat MD Alison L. Cameron MD Rick R. van Rijn MD Veronique Minard-Colin MD Ilaria Zanetti BSc Gianni Bisogno MD Julia C. Chisholm MD Johannes H. M. Merks MD 《Cancer》2023,129(16):2542-2552
Background
Limited data exist on the clinical behavior of pediatric non-rhabdomyosarcoma soft tissue sarcomas (NRSTS) with distant metastases at onset, and a clear standard of care has not yet been defined.Methods
This cohort study reports on pediatric adult-type metastatic NRSTS enrolled in two concurrent prospective European studies, i.e., the randomized BERNIE study and the single-arm MTS 2008 study developed by the European paediatric Soft tissue sarcoma Study Group. Treatment programs were originally designed for patients with metastatic rhabdomyosarcoma, i.e., nine courses of multidrug chemotherapy (with or without bevacizumab in the BERNIE study), followed by 12 cycles of maintenance therapy, whereas radiotherapy and/or surgery (on primary tumor and/or metastases) were delayed until after seven courses of chemotherapy had been administered.Results
The study included 61 patients <21 years old treated from July 2008 to December 2016. The lung was the site of metastases in 75% of the cases. All patients received multi-agent chemotherapy, 44% had local therapy to primary tumor, and 18% had treatment of metastases. Median time to progression/relapse was 6 months. A high rate of tumor progression was observed during the initial part of the chemotherapy program. With a median follow-up of 41.5 months (range, 2–111 months), 3-year event-free survival and overall survival were 15.4% (95% confidence interval [CI], 7.6–25.7) and 34.9% (95% CI, 22.7–47.5), respectively. There were no statistically significant differences in outcome depending on the type of treatment administered.Conclusions
The study confirmed the overall poor outcome for patients with metastatic NRSTS, whose treatment remains a challenge.Plain Language Summary
- Pediatric non-rhabdomyosarcoma soft tissue sarcomas form a heterogeneous group of rare tumors.
- Although recent international studies have defined the standard of care for patients with localized disease, limited data are available on the clinical behavior of patients with distant metastases.
- This study on 61 metastatic cases treated on two prospective European protocols confirms that the chances of survival of such patients are often dismal and a standard treatment is still lacking.
10.
【摘要】 目的:探讨手术治疗脊柱结核病灶清除术后合并感染的疗效分析。方法:回顾性分析2006年1月~2018年12月在我院骨科收治的因脊柱结核术后感染而再次手术的患者的资料18例,其中男性11例,女性7例,年龄27~76岁,平均46.6±18.3岁,随访12~36个月,平均18.6±6.5个月,统计合并症、首次手术方式、致病菌种类、手术时间、术中出血量、术后植骨融和情况等资料,统计手术前、术后2周以及末次随访Cobb角以及C反应蛋白(C-reactive protein,CRP)、血沉、疼痛视觉模拟评分(visual analogue scale,VAS);根据美国脊髓损伤协会损伤分级(American Spinal Injury Association,ASIA)分析患者手术前及末次随访时的截瘫程度的变化,综合上述因素,评价手术治疗脊柱结核术后感染的疗效分析及相关风险。结果:18例患者中,感染金黄色葡萄球菌4例,大肠埃希菌3例,肺炎克雷伯菌2例,表面葡萄球菌2例,溶血性葡萄球菌2例,厌氧菌1例,铜绿假单胞菌1例,阴沟肠杆菌1例;鲍曼不动杆菌2例。14例采取了单纯后路手术,4例采取了前后路联合的手术。手术时间为97~280min,出血量为100~1200ml。患者术前血沉45.6±25.8mm/h,CRP为38.3±42.0mg/L,VAS评分为6.3±1.5分,Cobb角为15.3°±6.7°;术后2周时血沉30.3±11.0mm/h,CRP为24.1±8.9mg/L,VAS评分2.4±1.2分,Cobb角12.6°±5.8°;末次随访血沉14.2±9.6mm/h,CRP为11.6±13.2mg/L,VAS评分为1.8±1.1分,Cobb角12.8°±4.7°,均有统计学差异(P<0.05)。1例ASIA B级患者术后恢复至D级、1例ASIA C级患者及4例ASIA D级患者末次随访时ASIA分级达到E级;有1例ASIA D级患者术后仍评为D级,但患者疼痛等症状明显恢复,生活基本自理。术后3~5个月植骨融合率100%。所有患者再次术后未见明显并发症。结论:脊柱结核术后感染的患者,经过充分抗感染、手术中彻底清除病灶、术后充分引流后,也能取得很好的治疗效果。 相似文献